Filter
1267
Text search:
Vaccine
production
Featured
144
309
Language
Document type
521
299
182
94
76
46
16
15
6
4
4
2
1
1
Countries / Regions
96
43
35
34
32
27
26
25
24
24
22
20
19
17
17
16
15
13
13
12
11
11
11
11
10
10
10
10
9
9
8
8
7
7
7
7
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
469
131
66
57
53
21
6
Toolboxes
215
61
59
57
46
43
43
37
32
32
29
27
25
23
20
19
18
14
12
11
10
7
6
4
1
12 May 2021. This third survey in the series shows that the COVID-19 pandemic continues to impact societies, not only in terms of health, but also social and economic conditions and day-to-day life
Entwicklungen und gegenwärtige Situationen der Covid-19-Impfstoffe
26 July 2021
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
A call for national and regional containment, recovery and prevention
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
10 points from field experience
Ending Cholera. A global roadmap to 2030
recommended
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
